Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Beryl Drugs Financial Results

Beryl Drugs reported annual revenue of ₹19.31 Crore for FY2026. The results include an unmodified audit opinion despite temporary manufacturing suspensions in the BFS section.

Key figures
Value₹19.31 Cr
Source

BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Beryl Drugs Ltd: key numbers

Share price
₹25.85
Market cap
₹13.11 Cr
Revenue (annual)
₹18.82 Cr
Net profit (annual)
₹0.42 Cr
P/E (TTM)
21.0×Sector 46.1×
Promoter holding
27.97%+0.15% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Beryl Drugs Ltd

All →

Other financial results announcements

All →